Related Experiment Video
Updated: Aug 16, 2025

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Rapid hydrogel-based phage susceptibility test for pathogenic bacteria
Sheetal Patpatia1, Eric Schaedig1, Anna Dirks1
1Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Abstract:
Phage therapy is one alternative to cure infections caused by antibiotic resistant bacteria. Due to the narrow host range of phages, hundreds to thousands of phages are required to cover the diversity of bacterial pathogens. In personalized phage therapy, fast selection of the phages for individual patients is essential for successful therapy. The aims of this study were to set up a rapid hydrogel-based liquid phage susceptibility assay (PST) for the selection of phages for therapeutic use and to establish a "ready-to-screen" plate concept, where phages are readily stored in hydrogel as small droplets in microtiter plate wells. We first tested four commercially available hydrogels (GrowDex, Askina, Purilon, and Intrasite) for their suitability as phage matrices in PSTs with four phages, two of which infecting Escherichia coli and two Staphylococcus aureus. Of these four hydrogels, GrowDex was the best matrix for PST, as it did not inhibit bacterial growth, released phages quickly when mixed with bacterial culture, and maintained phage viability well. We then optimized the assay for both optical density and microscopy readers using GrowDex as matrix with 23 bacterial strains representing 10 different species and 23 phages possessing different morphologies and genome sizes. When the bacterial growth was monitored by microscopy reader, the PST was executed in just 3 hours, and there was no need for overnight culturing bacterial cells prior to the assay, whereas using optical density reader, bacteria had to be pre-cultured overnight, and the assay time was five hours. Finally, we evaluated the effect of three different chemical stabilizers (trehalose, hyaluronic acid, and gelatin) in a six-month stability assay with six model phages. These phages assay behaved very differently in respect to the chemical stabilizers, and there was not a single stabilizer suitable for all phages. However, when gelatin (0.01%) or hyaluronic acid (0.2 mg/ml) was used as stabilizer, all tested phages were still considered as positives in PST after a six-month storage in 1 ml volume. In "ready-to-screen" plates, the differences in phage stabilities were even more profound, varying from two to six months for the most and least stable phages, respectively.
Insights
This study developed a rapid hydrogel-based phage susceptibility assay (PST) for personalized phage therapy. GrowDex hydrogel and specific stabilizers enable quick phage selection against antibiotic-resistant bacteria within hours.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Antibiotic resistance necessitates alternative treatments like phage therapy.
- Phage therapy requires selecting specific phages due to their narrow host range.
- Rapid phage selection is crucial for effective personalized phage therapy.
Purpose of the Study:
- To develop a rapid hydrogel-based liquid phage susceptibility assay (PST).
- To establish a "ready-to-screen" plate concept for phage storage.
- To optimize PST for different bacterial strains and phages.
Main Methods:
- Tested four hydrogels (GrowDex, Askina, Purilon, Intrasite) as phage matrices.
- Optimized PST using GrowDex with 23 bacterial strains and 23 phages.
- Evaluated chemical stabilizers (trehalose, hyaluronic acid, gelatin) for phage stability over six months.
Main Results:
- GrowDex hydrogel proved optimal for PST, showing no bacterial inhibition and good phage release/viability.
- Microscopy-based PST yielded results in 3 hours without pre-culturing; OD-based PST took 5 hours with pre-culturing.
- Gelatin and hyaluronic acid effectively stabilized phages for at least six months in liquid storage.
Conclusions:
- A rapid, hydrogel-based PST using GrowDex is feasible for selecting therapeutic phages.
- The "ready-to-screen" plate concept with stabilizers enhances phage therapy readiness.
- Optimized PST protocols significantly reduce assay time, facilitating personalized treatment approaches.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
07:22Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021